Last Updated: Sunday, December 5th 2021 12:59:31 PM EST
Melinda M. Lewis, M.D.
Research Interests
The application of new technology, including flow cytometry, FISH, PCR and mass spectrometry (SELDI-TOF) to enhance the diagnostic, prognostic and predictive power of cytologic specimens in breast cancer
Consultations: No
Focus Groups: No